Vesselon's Convertible Note - II Round

Vesselon raised a round of funding on July 05, 2016.

Vesselon is an early stage company creating an entirely new clinical domain for the treatment of stroke. Distinct from all approved drugs or devices, Vesselon's portable devices will treat patients be…

Articles about Vesselon's Convertible Note - II Round: